© Reuters. FILE PHOTO: A worker sweeps outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
(Reuters) – The U.S. Food and Drug Administration said on Wednesday there was a shortage of the drug Adderall, a treatment for attention deficit hyperactivity disorder (ADHD).
Be the first to comment